drugset / Trial / NCT04356300
Exosome of Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection
RandomizedParallel-groupSingle-blindTreatment
Summary
Multiple organ dysfunction syndrome (MODS) after surgical repaired for acute type A aortic dissection (ATAAD) is a life-threatening condition. In this study, patients who undergoing surgical repaired of ATAAD immediately or presenting sever MODS after surgical repaired of acute type A aortic dissection will be treated with umbilical cord-derived mesenchymal stem cell.
Timeline
- Start
- 2020-09-01
- Primary completion
- 2021-09-01
- Completion
- 2030-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exosome of MSC | Unknown | 150 mg | Intravenous |
| Subject | Exosome of MSC | Unknown | 180 mg | Intravenous |